XML 220 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Organization and significant accounting policies (Tables)
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revenues by Product Line
Total bioproduction products and services revenue for the years ended December 31, 2024, 2023, and 2022 were comprised of the following:
Years Ended December 31,
(In thousands, except percentages)202420232022
Product revenue
Cell processing$73,446 $65,772 $68,509 
Evo and thaw2,582 3,196 3,434 
Service revenue
Evo and thaw160 349 73 
Rental revenue
Evo and thaw6,066 6,538 4,223 
Total revenue$82,254 $75,855 $76,239 
Schedule of Earnings Per Share, Basic and Diluted
The following table presents computations of basic and diluted earnings per share:
Year Ended December 31,
(In thousands, except share and earnings per share data)202420232022
Basic and diluted (loss) income from continuing operations per common share
Numerator:
(Loss) income from continuing operations$(11,387)$(18,447)$388 
Denominator:
Weighted-average common shares issued and outstanding - Basic46,067,07343,719,18542,481,027
Effect of dilutive securities— — 592,446 
Weighted-average common shares issued and outstanding - Diluted46,067,073 43,719,185 43,073,473 
Net (loss) income per share from continuing operations attributable to common shareholders
Basic$(0.25)$(0.42)$0.01 
Diluted$(0.25)$(0.42)$0.01 
Anti-dilutive shares1,283,885 647,348 — 
Schedule of Product Revenue Concentration
The following is a summary of revenue by major product family representing over 10% of the Company's total revenue:
Years Ended December 31,
Revenue by major product202420232022
CryoStor73 %73 %77 %
Schedule of Revenue by Geographic Areas
The following table represents the Company’s total revenue by geographic area (based on the location of the customer):
Years Ended December 31,
Revenue by customers’ geographic locations(1)
202420232022
United States75 %82 %82 %
Europe, Middle East, Africa (EMEA)19 %12 %12 %
Other6 %6 %6 %
Total revenue100 %100 %100 %
(1) During the year ended December 31, 2023, the Company updated its methodology for determining the country of origin for its sales. Sales are now recorded by shipping country rather than billing country. The Company updated the methodology retrospectively, adjusting the prior year presentation for all regions presented.